DuChemBIO Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Revenue	-	35,601	34,695
Other Revenue	-	-	-0
Revenue	37,245	35,601	34,695
Revenue Growth (YoY)	7.35%	2.61%	-
Cost of Revenue	24,223	23,367	22,898
Gross Profit	13,022	12,234	11,797
Selling, General & Admin	5,920	5,548	5,087
Research & Development	-	-	205.31
Amortization of Goodwill & Intangibles	930.6	977.8	979.73
Operating Expenses	7,299	7,158	6,541
Operating Income	5,723	5,076	5,256
Interest Expense	-899.83	-1,091	-1,364
Interest & Investment Income	166.02	89.64	90.89
Earnings From Equity Investments	642.6	1,106	-69.64
Currency Exchange Gain (Loss)	-22.42	-34.84	-7.99
Other Non Operating Income (Expenses)	-45.15	30.23	68.38
EBT Excluding Unusual Items	5,564	5,177	3,974
Gain (Loss) on Sale of Investments	387.82	387.82	92.13
Gain (Loss) on Sale of Assets	-0.18	-0.18	16.28
Asset Writedown	-	-	-30.7
Pretax Income	5,952	5,564	4,052
Income Tax Expense	-1,789	-2,429	51.23
Net Income	7,740	7,994	4,001
Net Income to Common	7,740	7,994	4,001
Net Income Growth	93.48%	99.82%	-
Shares Outstanding (Basic)	28	27	27
Shares Outstanding (Diluted)	28	27	27
Shares Change (YoY)	5.49%	0.43%	-
EPS (Basic)	276.15	297.54	149.54
EPS (Diluted)	274.28	297.54	149.54
EPS Growth	83.41%	98.97%	-
Free Cash Flow	7,028	5,440	7,293
Free Cash Flow Per Share	249.02	202.48	272.63
Gross Margin	34.96%	34.36%	34.00%
Operating Margin	15.37%	14.26%	15.15%
Profit Margin	20.78%	22.45%	11.53%
Free Cash Flow Margin	18.87%	15.28%	21.02%
EBITDA	11,519	10,641	11,016
EBITDA Margin	30.93%	29.89%	31.75%
D&A For EBITDA	5,796	5,565	5,760
EBIT	5,723	5,076	5,256
EBIT Margin	15.37%	14.26%	15.15%
Effective Tax Rate	-	-	1.26%
Advertising Expenses	-	76.18	62.35

Source: S&P Global Market Intelligence. Standard template. Financial Sources.